DERMARX CORP
10QSB/A, 1996-03-15
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Previous: ASTEC INDUSTRIES INC, 10-K, 1996-03-15
Next: LUXTEC CORP /MA/, 10-Q, 1996-03-15



<PAGE>


                    SECURITIES AND EXCHANGE COMMISSION
                          Washington, D.C. 20549
                                     
                                FORM 10-QSB
                                     
[X]          QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
                   OF THE SECURITIES EXCHANGE ACT OF 1934
                                     
                      For the quarterly period ended
                             NOVEMBER 30, 1995
                                     
                                    OR
                                     
[ ]        TRANSITIONAL REPORT PURSUANT TO SECTION 13 OR 15(d)
                    OF THE SECURITIES EXCHANGE ACT OF 1934
                                     
                     COMMISSION FILE NUMBER:  33-5384
                                     
                            DERMARX CORPORATION
          (Exact name of registrant as specified in its charter)
                                      
                    DELAWARE                           13-3301899
           (State or other jurisdiction of           (IRS Employer
            incorporation or organization)        Identification No.)
                                                 
            400 COLORADO BLVD., SUITE 420                   
                 DENVER, COLORADO                         80206
           (Address of principal executive             (Zip Code)
             offices)
                                     
Registrant's telephone number, including area code:  (303) 399-1632

      Indicate  by  check mark whether the registrant  (X)  has  filed  all
reports  required  to  be filed by Section 13 or 15(d)  of  the  Securities
Exchange  Act  of 1934 during the preceding 12 months (or for such  shorter
period  that the registrant was required to file such reports) and (2)  has
been subject to such filing requirements for the past 90 days.  Yes [  X  ]
No [     ]

      Indicate  the  number of shares outstanding of each of  the  issuer's
classes  of  common  stock, as of the latest practicable  date:   7,199,034
shares (as of February 29, 1996) of common stock, par value $.01 per share.



<PAGE>
                              

                            SIGNATURE
                                
      Pursuant to the requirements of the Securities Exchange Act
of  1934, the registrant has duly caused this report to be signed
on its behalf by the undersigned thereunto duly authorized.



                                   DERMARX CORPORATION
                                   (Registrant)



Dated:    March 8, 1996.               /s/ Maryanne Carroll
                                       -----------------------
                                       Maryanne Carroll,
                                       Chief Executive Officer


                               7



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission